These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6779769)

  • 1. [Hemodynamic effects of prazosin in chronic congestive heart failure].
    Bassand JP; Becque O; Berthout P; Vial Y; Magnin D; Bernard Y; Maurat JP
    Arch Mal Coeur Vaiss; 1980 Jun; 73(6):747-56. PubMed ID: 6779769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic administration of prazosin in patients with congestive cardiomyopathy (author's transl)].
    Kuhn H; Boch H; Lösse B
    Z Kardiol; 1981 Jul; 70(7):501-7. PubMed ID: 7269730
    [No Abstract]   [Full Text] [Related]  

  • 3. [Captopril in chronic congestive heart failure--dose-effect behavior and comparison with prazosin].
    Froer KL; Hall D; Rudolph W
    Herz; 1983 Apr; 8(2):81-7. PubMed ID: 6343211
    [No Abstract]   [Full Text] [Related]  

  • 4. [Correlations between resting hemodynamics and exercise tolerance before and after prazosin therapy in patients with chronic congestive heart failure].
    Ogawa T; Sekiguchi T; Ishii M; Sugishita Y; Ito I
    Kokyu To Junkan; 1985 Feb; 33(2):171-7. PubMed ID: 4001595
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of alpha-receptor blockade with prazosin in advanced chronic congestive heart failure.
    Lui HK; Awan NA; Mason DT
    Herz; 1983 Apr; 8(2):65-70. PubMed ID: 6303929
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
    Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350
    [No Abstract]   [Full Text] [Related]  

  • 8. [Haemodynamic effects and plasma concentrations of prazosin in chronic heart failure (author's transl)].
    Pornin M; Decourt S; Sellier P; Guermonprez JL; Ourbak P; Maurice P; Flouvat B
    Therapie; 1981; 36(4):435-42. PubMed ID: 7292426
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
    Reifart N; Schmidt-Moritz AD; Nadj M; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Apr; 74(4):205-12. PubMed ID: 3923726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effects of prazosin in heart failure].
    Bassand JP; Becque O; Vial Y; Berthout P; Maurat JP
    Nouv Presse Med; 1979 Nov; 8(44):3663. PubMed ID: 534219
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure].
    Kersting F; Samosny G; Kasper W; Schuster HP
    Med Welt; 1981 Jun; 32(26):1040-5. PubMed ID: 6114383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)].
    Yui Y; Nakajima H; Sakurai K; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1981 Jul; 29(7):723-6. PubMed ID: 7291740
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and polycardiographic evaluation of prazosin in the treatment of chronic congestive heart failure].
    Szmydt W; Kaftańska A; Paradowski S
    Pol Tyg Lek; 1984 Nov; 39(46):1509-12. PubMed ID: 6393093
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic effect of prazosin in patients with aortic and mitral valve insufficiency].
    Rumiński W; Markiewicz M; Przegaliński J
    Pol Tyg Lek; 1983 Sep; 38(39):1211-4. PubMed ID: 6674950
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative hemodynamic effect of sodium nitroprusside and prazosin hydrochloride in patients with cardiac insufficiency following acute myocardial infarction].
    López-Sendón J; Coma Canella I
    Rev Esp Cardiol; 1981; 34(1):55-61. PubMed ID: 7280350
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effects of prazosin in patients with chronic refractory heart failure-acute hemodynamic effects of oral prazosin and long-term therapy (author's transl)].
    Honda T; Hiramori K; Haze K; Saito M; Fuseno H; Fukami K; Umemoto M; Tanaka N; Ikeda M
    Kokyu To Junkan; 1981 May; 29(5):527-35. PubMed ID: 7313357
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemodynamic effects and clinical observations on prazosin in treating chronic refractory congestive heart failure].
    Shen LH; Ku FS; Liu QS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):244-7, 315. PubMed ID: 6544203
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prazosin in heart insufficiency. Short-term hospital clinical trial].
    Sánchez Domińguez J; González Villa J; Urbina Fuentes FJ; Menéndez Lozano A
    Rev Clin Esp; 1981 Mar; 160(6):371-6. PubMed ID: 7255801
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prazosin in the treatment of chronic resistant heart failure].
    Kleinman Y; Tzivoni D
    Harefuah; 1981 Apr; 100(8):398-401. PubMed ID: 7274816
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
    Packer M; Meller J; Gorlin R; Herman MV
    Circulation; 1979 Mar; 59(3):531-9. PubMed ID: 761333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.